Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition

OBJECTIVE: Sodium–glucose cotransporter 2 (SGLT2) inhibitors cause substantially less weight loss than expected from the energy excreted via glycosuria. Our aim was to analyze this phenomenon quantitatively. RESEARCH DESIGN AND METHODS: Eighty-six patients with type 2 diabetes (HbA(1c) 7.8 ± 0.8% [6...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Care
Hlavní autoři: Ferrannini, Giulia, Hach, Thomas, Crowe, Susanne, Sanghvi, Arjun, Hall, Kevin D., Ferrannini, Ele
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2015
Témata:
Emerging Technologies and Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542276/
https://ncbi.nlm.nih.gov/pubmed/26180105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc15-0355
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky